ArticleJournal of the American Heart Association2022

Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.

Malcolm West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.